Company Magnasense AB

Equities

AEGIR

SE0014401121

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm 12:00:00 2024-07-10 pm EDT 5-day change 1st Jan Change
0.4005 SEK -5.43% Intraday chart for Magnasense AB -6.86% -65.77%

Business Summary

AegirBio AB is a Sweden-based medicine company focused therapeutic drug monitoring of biologic therapies in the autoimmune, oncology and neurology space. The Company offers tests to monitor and optimize the dosage of biological drugs via its patented technology platform. It aims to provide personalized treatment by tracking drugs levels in individuals. Aegirbio combines core technologies from LifeAssays and Abreos Biosciences. LifeAssays is a diagnostics company based in Sweden, which owns the Magnia Point of Care and Point of Need reader technology. Abreos Biosciences is a California-based biotech, which is a developer of the Veritope chemistry platform for detecting levels of biologic drugs in patient samples.

Number of employees: 14

Sales per Business

SEK in Million2022Weight2023Weight Delta
Other
100.0 %
- - 0 100.0 % -

Sales per region

SEK in Million2022Weight2023Weight Delta
Finland
55.4 %
0 0.0 % 0 55.4 % -
Sweden
44.6 %
1 82.2 % 0 44.6 % -97.08%

Managers

Managers TitleAgeSince
Chief Executive Officer - 23-06-14
Director of Finance/CFO 57 23-04-18
Chief Operating Officer 45 Oct. 31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 49 20-04-30
Director/Board Member 57 22-05-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 30,876,872 28,180,538 ( 91.27 %) 0 91.27 %

Company contact information

AegirBio AB

Scheelevägen 27

223 63, Lund

+46 4 62 86 54 00

http://www.aegirbio.com
address Magnasense AB(AEGIR)